683 Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-790,000
| Closed | -$7.9M | – | 301 |
|
|
2022
Q1 | $7.9M | Buy |
790,000
+200,000
| +34% | +$2M | 0.42% | 58 |
|
|
2021
Q4 | $5.84M | Buy |
590,000
+440,000
| +293% | +$4.35M | 0.21% | 74 |
|
|
2021
Q3 | $1.49M | Hold |
150,000
| – | – | 0.06% | 118 |
|
|
2021
Q2 | $1.55M | Hold |
150,000
| – | – | 0.05% | 125 |
|
|
2021
Q1 | $1.53M | Hold |
150,000
| – | – | 0.08% | 96 |
|
|
2020
Q4 | $1.71M | Buy |
+150,000
| New | +$1.71M | 0.08% | 90 |
|